- MFDS and US FDA Sign Memorandum of Cooperation to Accelerate Medical Product Development Using Artificial Intelligence (AI)

- MFDS and US FDA recognize the importance of international harmonization in the digital health sector...work together to revitalize development

- Discussion with the USP on how to facilitate research on standard drug products and human resource exchange

- Multifaceted cooperation with overseas regulatory agencies...striving to make our regulations the standard for global regulation

On the occasion of the state visit of President Yoon Suk Yeol, the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea (Minister Oh Yu-Kyoung) met with Dr. Robert M. Califf, Commissioner of the US Food and Drug Administration (FDA) to discuss cooperation between the two organizations in the field of digital health and signed a Memorandum of Cooperation (MOC*) on April 27 (local time) to strengthen cooperation on medical products using artificial intelligence (AI).